MedPath

Glyburide

for oral use These highlights do not include all the information needed to use Glyburide safely and effectively. See full prescribing information for Glyburide Glyburide (Glyburide) TABLET for ORAL use. Initial U.S. Approval:

Approved
Approval ID

901c513c-9e35-b06c-e053-2995a90adfcc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 19, 2021

Manufacturers
FDA

NuCare Pharmaceuticals,Inc.

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Glyburide

PRODUCT DETAILS

NDC Product Code68071-5029
Application NumberANDA090937
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateFebruary 19, 2021
Generic NameGlyburide

INGREDIENTS (5)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
GLYBURIDEActive
Quantity: 2.5 mg in 1 1
Code: SX6K58TVWC
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Glyburide - FDA Drug Approval Details